Our data showed that PEP005 treatment caused a significant reduction in the expression of all these HIV receptors/co-receptors, suggesting that PEP005 may not pose the risk of increasing susceptibility of CD4+ T cells to HIV infection during its reactivation of HIV latency (Fig 12A). Here, CD4 is linked to HIV infectious disease.